| RS2118848876 |
GRHPR
|
Health Risk |
Pathogenic |
— |
| RS2118849212 |
GRHPR
|
Health Risk |
Pathogenic |
Primary hyperoxaluria, type II |
| RS2118857318 |
TGFBR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS2118858700 |
TGFBR1
|
Health Risk |
Likely pathogenic |
Loeys-Dietz syndrome 1, Loeys-Dietz syndrome 1 |
| RS2118863163 |
GRHPR
|
Health Risk |
Pathogenic |
— |
| RS2118863170 |
GRHPR
|
Health Risk |
Pathogenic |
— |
| RS2118864015 |
ASS1
|
Health Risk |
Likely pathogenic |
Citrullinemia, Citrullinemia type I |
| RS2118864334 |
ASS1
|
Health Risk |
Pathogenic |
Citrullinemia, Citrullinemia |
| RS2118864687 |
ABCA1
|
Health Risk |
Pathogenic |
— |
| RS2118865591 |
GRHPR
|
Health Risk |
Pathogenic |
— |
| RS2118873472 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Hereditary cancer-predisposing syndrome |
| RS2118873547 |
PTCH1
|
Health Risk |
Likely pathogenic |
Gorlin syndrome, Hereditary cancer-predisposing syndrome |
| RS2118874002 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS2118874752 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS2118875429 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS2118875526 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS2118876177 |
PTCH1
|
Health Risk |
Likely pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS2118876450 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS2118878946 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS2118879154 |
PTCH1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2118879343 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Hereditary cancer-predisposing syndrome |
| RS2118879524 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS2118880072 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS2118880115 |
ASS1
|
Health Risk |
Pathogenic |
Citrullinemia, Citrullinemia |
| RS2118880130 |
GRHPR
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type II |
| RS2118880152 |
GRHPR
|
Health Risk |
Pathogenic |
— |
| RS2118880170 |
ASS1
|
Health Risk |
Likely pathogenic |
Citrullinemia type I, Citrullinemia type I |
| RS2118880266 |
ASS1
|
Health Risk |
Pathogenic |
Citrullinemia, Citrullinemia type I |
| RS2118880626 |
ASS1
|
Health Risk |
Pathogenic |
Citrullinemia, Citrullinemia |
| RS2118881561 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS2118907171 |
ELP1
|
Health Risk |
Likely pathogenic |
Familial dysautonomia, Familial dysautonomia |
| RS2118908187 |
PTCH1
|
Health Risk |
Likely pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS2118910332 |
PTCH1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2118910919 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2118912529 |
ABCA1
|
Health Risk |
Pathogenic |
— |
| RS2118925108 |
ELP1
|
Health Risk |
Pathogenic |
— |
| RS2118927777 |
TRPM6
|
Health Risk |
Pathogenic |
Intestinal hypomagnesemia 1, Intestinal hypomagnesemia 1 |
| RS2118933859 |
ELP1
|
Health Risk |
Likely pathogenic |
Familial dysautonomia, Familial dysautonomia |
| RS2118934288 |
ELP1
|
Health Risk |
Pathogenic |
— |
| RS2118936334 |
ELP1
|
Health Risk |
Likely pathogenic |
Familial dysautonomia, Familial dysautonomia |
| RS2118938912 |
ELP1
|
Health Risk |
Pathogenic |
— |
| RS2118966321 |
TOPORS
|
Health Risk |
Likely pathogenic |
— |
| RS2118966836 |
TOPORS
|
Health Risk |
Pathogenic |
— |
| RS2118968698 |
TOPORS
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS2118977758 |
EXOSC3
|
Health Risk |
Likely pathogenic |
Pontocerebellar hypoplasia type 1B, Pontocerebellar hypoplasia type 1B |
| RS2118980158 |
EXOSC3
|
Health Risk |
Pathogenic |
Pontocerebellar hypoplasia type 1B, Pontocerebellar hypoplasia type 1B |
| RS2118980242 |
EXOSC3
|
Health Risk |
Pathogenic |
Pontocerebellar hypoplasia type 1B, Pontocerebellar hypoplasia type 1B |
| RS2118986578 |
LMX1B
|
Health Risk |
Pathogenic |
— |
| RS2118986608 |
LMX1B
|
Health Risk |
Pathogenic |
— |
| RS2118986658 |
LMX1B
|
Health Risk |
Pathogenic |
— |
| RS2118986709 |
LMX1B
|
Health Risk |
Pathogenic |
— |
| RS2118986877 |
LMX1B
|
Health Risk |
Pathogenic |
— |
| RS2118986919 |
LMX1B
|
Health Risk |
Pathogenic |
— |
| RS2118986952 |
LMX1B
|
Health Risk |
Likely pathogenic |
— |
| RS2118986969 |
LMX1B
|
Health Risk |
Pathogenic |
— |
| RS2118987040 |
LMX1B
|
Health Risk |
Pathogenic |
Nail-patella syndrome, Nail-patella syndrome |
| RS2118987177 |
LMX1B
|
Health Risk |
Pathogenic |
— |
| RS2118991726 |
LMX1B
|
Health Risk |
Pathogenic |
— |
| RS2118991973 |
LMX1B
|
Health Risk |
Likely pathogenic |
— |
| RS2118992231 |
LMX1B
|
Health Risk |
Pathogenic |
— |
| RS2118992738 |
LMX1B
|
Health Risk |
Pathogenic |
— |
| RS2118992752 |
LMX1B
|
Health Risk |
Pathogenic |
— |
| RS2118992878 |
LMX1B
|
Health Risk |
Pathogenic |
— |
| RS2118993320 |
LMX1B
|
Health Risk |
Pathogenic |
— |
| RS2118997138 |
LMX1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Nail-patella syndrome, Nail-patella-like renal disease |
| RS2119013151 |
BAAT
|
Health Risk |
Pathogenic |
Bile acid conjugation defect 1, Bile acid conjugation defect 1 |
| RS2119034662 |
ABCA1
|
Health Risk |
Pathogenic |
— |
| RS2119062642 |
CEL
|
Health Risk |
Likely pathogenic |
— |
| RS2119079745 |
SURF1
|
Health Risk |
Pathogenic |
Leigh syndrome, Leigh syndrome |
| RS2119079774 |
SURF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex IV deficiency, nuclear type 1 |
| RS2119079909 |
SURF1
|
Health Risk |
Likely pathogenic |
Leigh syndrome, Leigh syndrome |
| RS2119079986 |
SURF1
|
Health Risk |
Pathogenic |
— |
| RS2119080054 |
SURF1
|
Health Risk |
Likely pathogenic |
— |
| RS2119081117 |
SURF1
|
Health Risk |
Pathogenic |
Leigh syndrome, Leigh syndrome |
| RS2119081217 |
SURF1
|
Health Risk |
Pathogenic |
Leigh syndrome, Leigh syndrome |
| RS2119081408 |
SURF1
|
Health Risk |
Pathogenic |
Mitochondrial complex IV deficiency, nuclear type 1 |
| RS2119083367 |
SURF1
|
Health Risk |
Pathogenic |
Leigh syndrome, Leigh syndrome |
| RS2119083553 |
SURF1
|
Health Risk |
Pathogenic |
Leigh syndrome, Mitochondrial complex IV deficiency |
| RS2119085025 |
SURF1
|
Health Risk |
Pathogenic |
Leigh syndrome, Leigh syndrome |
| RS2119085056 |
SURF1
|
Health Risk |
Pathogenic |
Leigh syndrome, Leigh syndrome |
| RS2119085074 |
SURF1
|
Health Risk |
Pathogenic |
Leigh syndrome, Leigh syndrome |
| RS2119088472 |
SURF1
|
Health Risk |
Pathogenic |
Leigh syndrome, Leigh syndrome |
| RS2119089032 |
SURF1
|
Health Risk |
Likely pathogenic |
Leigh syndrome, Leigh syndrome |
| RS2119186288 |
AGPAT2
|
Health Risk |
Pathogenic |
Congenital generalized lipodystrophy, Congenital generalized lipodystrophy |
| RS2119445087 |
FAS
|
Health Risk |
Pathogenic/Likely pathogenic |
Autoimmune lymphoproliferative syndrome type 1, Autoimmune lymphoproliferative syndrome type 1 |
| RS2119445224 |
FAS
|
Health Risk |
Pathogenic |
Autoimmune lymphoproliferative syndrome type 1, Autoimmune lymphoproliferative syndrome type 1 |
| RS2119445406 |
FAS
|
Health Risk |
Likely pathogenic |
— |
| RS2119446096 |
FAS
|
Health Risk |
Likely pathogenic |
Autoimmune lymphoproliferative syndrome type 1, Autoimmune lymphoproliferative syndrome type 1 |
| RS2119446366 |
FAS
|
Health Risk |
Pathogenic |
Autoimmune lymphoproliferative syndrome type 1, Autoimmune lymphoproliferative syndrome type 1 |
| RS2119446879 |
FAS
|
Health Risk |
Pathogenic |
Autoimmune lymphoproliferative syndrome type 1, Autoimmune lymphoproliferative syndrome type 1 |
| RS2119448150 |
FAS
|
Health Risk |
Conflicting classifications of pathogenicity |
Autoimmune lymphoproliferative syndrome type 1, Autoimmune lymphoproliferative syndrome type 1 |
| RS2119807637 |
CCDC186
|
Health Risk |
Pathogenic |
10 conditions, 10 conditions |
| RS2119818223 |
SOX6
|
Health Risk |
Pathogenic |
Tolchin-Le Caignec syndrome, Tolchin-Le Caignec syndrome |
| RS2119818229 |
SOX6
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2119819668 |
SOX6
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2119905910 |
FGF3
|
Health Risk |
Likely pathogenic |
Deafness with labyrinthine aplasia, microtia |
| RS2119929795 |
FGF3
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2120049760 |
LRRC32
|
Health Risk |
Likely pathogenic |
Cleft palate, proliferative retinopathy |
| RS2120355008 |
DHCR7
|
Health Risk |
Likely pathogenic |
Smith-Lemli-Opitz syndrome, Smith-Lemli-Opitz syndrome |
| RS2120360235 |
KMT2D
|
Health Risk |
Likely pathogenic |
Kabuki syndrome, Kabuki syndrome |